Related Experiment Video
Updated: May 20, 2025

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
Clinical characteristics and diagnostic practices in nontuberculous mycobacterial pulmonary disease: Insights from
Victor Naestholt Dahl1, Andreas Fløe2, Frauke Rudolf3
1Department of Infectious Diseases, Aarhus University Hospital, Aarhus, Denmark; Center for Global Health, Department of Public Health, Aarhus University (GloHAU), Aarhus, Denmark; International Reference Laboratory of Mycobacteriology, Statens Serum Institut, Copenhagen, Denmark.
Background:
Clinical characteristics of patients with nontuberculous mycobacterial pulmonary disease (NTM-PD) in Denmark are undescribed. This study investigated clinical characteristics and diagnostic practices in patients with pulmonary NTM isolates.
Methods:
Patients in Central Region Denmark from 2016 to 2021 were identified using mycobacterial reference laboratory data, and hospital records were reviewed for demographics, comorbidities, risk factors, and diagnostic details. Diagnostic guideline criteria for NTM-PD were assessed, and clinical characteristics were compared between those who met the criteria and those who did not.
Results:
Among 193 patients, M. avium complex (56 %), M. gordonae (15 %), and M. xenopi (11 %) were most common. Symptoms included cough (62 %), expectoration (51 %), dyspnea (43 %), and systemic symptoms (42 %), with 36 % experiencing symptoms for over 6 months. The median time from first hospital contact to receipt of the first sample yielding NTM was 14 days (IQR: 42). Forty-five percent (n = 87) of patients were initially seen in a fast-track pulmonary cancer referral pathway. Fifty-three percent (n = 103) met the diagnostic criteria for NTM-PD. This was associated with older age, lower BMI and FEV1, a higher comorbidity burden, longer time to diagnostic sampling, and higher bacterial loads.
Conclusions:
In Denmark, a high percentage of patients met the NTM-PD criteria compared to other studies, which may be attributed to a high prevalence of structural lung disease and delayed disease presentation and diagnosis. Many patients were initially seen in a fast-track pulmonary cancer pathway, which could be leveraged to improve the diagnostic pathway of NTM-PD.
More Related Videos
09:54Synthesis, Characterization, and Application of Superparamagnetic Iron Oxide Nanoprobes for Extrapulmonary Tuberculosis Detection
Published on: February 16, 2020
05:40Preparation of Agar Bead Embedded Mycobacterium abscessus to Inoculate Immunocompetent Mice Intratracheally
Published on: April 25, 2025
Related Concept Videos
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pneumonia III: Complications and Assessment